BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 26209730)

  • 1. Second harmonic generation microscopy is a novel technique for differential diagnosis of breast fibroepithelial lesions.
    Tan WJ; Yan J; Xu S; Thike AA; Bay BH; Yu H; Tan MH; Tan PH
    J Clin Pathol; 2015 Dec; 68(12):1033-5. PubMed ID: 26209730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A five-gene reverse transcription-PCR assay for pre-operative classification of breast fibroepithelial lesions.
    Tan WJ; Cima I; Choudhury Y; Wei X; Lim JC; Thike AA; Tan MH; Tan PH
    Breast Cancer Res; 2016 Mar; 18(1):31. PubMed ID: 26961242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroepithelial lesions; The WHO spectrum.
    Krings G; Bean GR; Chen YY
    Semin Diagn Pathol; 2017 Sep; 34(5):438-452. PubMed ID: 28688536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precise diagnosis of breast phyllodes tumors using Raman spectroscopy: Biochemical fingerprint, tumor metabolism and possible mechanism.
    Wu Y; Wang Y; He C; Wang Y; Ma J; Lin Y; Zhou L; Xu S; Ye Y; Yin W; Ye J; Lu J
    Anal Chim Acta; 2023 Dec; 1283():341897. PubMed ID: 37977771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of fibroepithelial tumours of the breast.
    Badhe BA; Iyengar KR; Alva N
    Indian J Cancer; 2002; 39(3):91-6. PubMed ID: 12928563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of phyllodes tumours on core biopsy specimens of fibroepithelial neoplasms.
    Jara-Lazaro AR; Akhilesh M; Thike AA; Lui PC; Tse GM; Tan PH
    Histopathology; 2010 Aug; 57(2):220-32. PubMed ID: 20716164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phyllodes tumors and fibroadenoma common beginning and different ending.
    Oprić S; Oprić D; Gugić D; Granić M
    Coll Antropol; 2012 Mar; 36(1):235-41. PubMed ID: 22816226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammary fibroadenoma and some phyllodes tumour stroma are composed of CD34+ fibroblasts and factor XIIIa+ dendrophages.
    Silverman JS; Tamsen A
    Histopathology; 1996 Nov; 29(5):411-9. PubMed ID: 8951485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phyllodes tumours of the breast diagnosed as B3 category on image-guided 14-gauge core biopsy: analysis of 51 cases from a single institution and review of the literature.
    Abdulcadir D; Nori J; Meattini I; Giannotti E; Boeri C; Vanzi E; Vezzosi V; Bianchi S
    Eur J Surg Oncol; 2014 Jul; 40(7):859-64. PubMed ID: 24612651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paediatric fibroepithelial lesions revisited: pathological insights.
    Tay TK; Chang KT; Thike AA; Tan PH
    J Clin Pathol; 2015 Aug; 68(8):633-41. PubMed ID: 25998513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histological features useful in the distinction of phyllodes tumour and fibroadenoma on needle core biopsy of the breast.
    Lee AH; Hodi Z; Ellis IO; Elston CW
    Histopathology; 2007 Sep; 51(3):336-44. PubMed ID: 17727475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasonography and core needle biopsy in the differential diagnosis of fibroadenoma and tumor phyllodes.
    Bode MK; Rissanen T; Apaja-Sarkkinen M
    Acta Radiol; 2007 Sep; 48(7):708-13. PubMed ID: 17728999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phyllodes tumour of the breast: immunohistochemical study of 37 tumours using MIB1 antibody.
    Kocová L; Skálová A; Fakan F; Rousarová M
    Pathol Res Pract; 1998; 194(2):97-104. PubMed ID: 9584322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computer-Aided Detection of Quantitative Signatures for Breast Fibroepithelial Tumors Using Label-Free Multi-Photon Imaging.
    Kobayashi-Taguchi K; Saitou T; Kamei Y; Murakami A; Nishiyama K; Aoki R; Kusakabe E; Noda H; Yamashita M; Kitazawa R; Imamura T; Takada Y
    Molecules; 2022 May; 27(10):. PubMed ID: 35630817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroepithelial lesions with cellular stroma on breast core needle biopsy: are there predictors of outcome on surgical excision?
    Jacobs TW; Chen YY; Guinee DG; Holden JA; Cha I; Bauermeister DE; Hashimoto B; Wolverton D; Hartzog G
    Am J Clin Pathol; 2005 Sep; 124(3):342-54. PubMed ID: 16191502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast.
    Kuijper A; van der Groep P; van der Wall E; van Diest PJ
    Breast Cancer Res; 2005; 7(5):R808-18. PubMed ID: 16168127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Management Algorithm for the Diagnosis of Cellular Fibroepithelial Lesions From Core Needle Biopsies.
    Jung J; Kang E; Chae SM; Kim H; Park SY; Yun B; Kim SM; Jang M; Kim SW; Kim EK
    Int J Surg Pathol; 2018 Dec; 26(8):684-692. PubMed ID: 29774785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which lesions with a radiological or core biopsy diagnosis of fibroadenoma should be excised?
    Lee A; James J; Whisker L; Rakha EA; Ellis IO
    Ann R Coll Surg Engl; 2022 May; 104(5):361-366. PubMed ID: 34939848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroepithelial lesions of the breast: A review of recurring diagnostic issues.
    Seow DYB; Tay TKY; Tan PH
    Semin Diagn Pathol; 2022 Sep; 39(5):333-343. PubMed ID: 35523613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Core needle biopsy diagnosis of fibroepithelial lesions of the breast: a diagnostic challenge.
    Li JJX; Tse GM
    Pathology; 2020 Oct; 52(6):627-634. PubMed ID: 32771211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.